Drugmaker Wockhardt on Friday said research and trials on the antibiotic Zaynich are progressing satisfactorily, and it is aiming for an early FY26 launch. Zaynich has a market potential ...
Exchange-traded currency derivatives volumes are likely to drop in view of new Reserve Bank of India (RBI) rules, casting a cloud over further participation of retail investors and proprietary ...
Healthcare stocks have outperformed the benchmark indices since the start of the current financial year. The BSE Healthcare Index is up 19 per cent as compared to BSE Sensex ...